Higher indexed body fat mass was associated with improved 5-year survival compared to lower indexed body fat mass in heart failure patients (90.2% vs 80.1%, P=0.008).
Cohort (n=359)
Are higher body fat mass and lean body mass associated with improved survival in outpatients with heart failure?
Higher body fat mass and, to a lesser extent, higher lean mass are associated with improved 5-year survival in heart failure outpatients, providing further evidence for the obesity paradox.
Effect estimate: HR 0.89
Absolute Event Rate: 90.2% vs 80.1%
p-value: p=0.008
Background Studies have shown that higher body mass index (BMI) is associated with improved prognosis in heart failure (HF), and this is often termed the obesity paradox. Hypothesis Analysis of body composition may reveal that muscle mass rather than adipose tissue accounts for the obesity paradox. Methods Bioelectrical impedance analysis of body composition in 359 outpatients with HF was performed using an In Body 520 body composition scale (Biospace Inc., California). Body fat and lean mass were indexed by height (m 2 ). The cohort was stratified by median fat and lean mass indexed by height. Results The mean age of patients studied was 56 ± 14; mean left ventricular ejection fraction was 38 ± 16%. Patients with higher indexed body fat mass had improved 5‐year survival over patients with lower indexed body fat mass (90.2% vs 80.1%, P = 0.008). There was also improved survival in patients with high vs low indexed lean body mass (89.3% vs 80.9%, P = 0.036). On multivariable analysis, higher indexed body fat mass, but not lean body mass, was independently associated with improved survival (HR 0.89, per kg/m 2 increase in indexed body fat mass, P = 0.044); however, this was attenuated after adjustment for diabetes. The combination of low lean with low‐fat mass was independently associated with poor prognosis. Conclusions Our data suggest that higher fat mass—and to a lesser extent higher lean mass—is associated with improved outcomes in HF. Further investigations of specific components of body composition and outcomes in HF are warranted.
Thomas et al. (Sat,) conducted a cohort in Heart failure (n=359). High indexed body fat mass vs. Low indexed body fat mass was evaluated on 5-year survival (HR 0.89, p=0.008). Higher indexed body fat mass was associated with improved 5-year survival compared to lower indexed body fat mass in heart failure patients (90.2% vs 80.1%, P=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: